pifithrin has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 2 studies
pifithrin: a tetrahydrobenzothiazol; inhibitor of P53 that protects mice from the side effects of cancer therapy; structure in first source
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Duan, W | 1 |
Zhu, X | 1 |
Ladenheim, B | 1 |
Yu, QS | 1 |
Guo, Z | 1 |
Oyler, J | 1 |
Cutler, RG | 1 |
Cadet, JL | 1 |
Greig, NH | 1 |
Mattson, MP | 1 |
Liang, ZQ | 1 |
Li, YL | 1 |
Zhao, XL | 1 |
Han, R | 1 |
Wang, XX | 1 |
Wang, Y | 1 |
Chase, TN | 1 |
Bennett, MC | 1 |
Qin, ZH | 1 |
2 other studies available for pifithrin and Autosomal Dominant Juvenile Parkinson Disease
Article | Year |
---|---|
p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apoptosis; bcl-2-Associated X Protein; Behavi | 2002 |
NF-kappaB contributes to 6-hydroxydopamine-induced apoptosis of nigral dopaminergic neurons through p53.
Topics: Active Transport, Cell Nucleus; Animals; Apoptosis; Benzothiazoles; DNA Fragmentation; Dopamine; Mal | 2007 |